Shore Capital view: Creo Medical (‘CREO’) is at a commercial inflection point. In FY25, sales of its surgical endoscopy tools grew substantially (+50%) despite a tightening cost base (-20%), establishing that
Shore Capital view: Creo Medical (‘CREO’) is at a commercial inflection point. In FY25, sales of its surgical endoscopy tools grew substantially (+50%) despite a tightening cost base (-20%), establishing that
The AIM All-Share had one of its best weeks of the year, rising 1.7% to 792. However, it still lagged behind the FTSE 100, which climbed 2% to reach record
Alliance News: The UK Treasury plans to give a stamp duty holiday to investors in new stock market listings in London in an attempt to encourage more initial public offerings, the
Keir Starmer backed Volodymyr Zelensky in a phone call on Wednesday after Donald Trump claimed the Ukrainian president was “a dictator without elections”. In the call, the UK prime minister
Lift Global Ventures (AQSE:LFT), an investment company focused on financial media, technology and the energy sector, announced that one of its investment portfolio companies, Trans-Africa Energy Limited, has secured conditional equity
Although the news was widely distributed yesterday, presumably to give shareholders an extra bad night’s sleep,
There was a late Christmas present for shareholders of Russia focused PGM producer Eurasia Mining (EUA), as the company adopted a dividend policy. Rather tantalisingly, this is set to be
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Grab a coffee, settle down and listen to the guy’s view – thoughts covering this week in the markets. New and exclusive to Share Talk
A Change Of Name